Biological and toxic properties of deferoxamine.
Freedman
M H
MH
Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Canada.
Bentur
Y
Y
Koren
G
G
D002386:Cataract / Q000139:chemically induced; D002455:Cell Division / Q000187:drug effects; D004247:DNA / Q000037:antagonists & inhibitors; D003676:Deferoxamine / Q000009:adverse effects* / Q000494:pharmacology; D004342:Drug Hypersensitivity / Q000209:etiology; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D013789:Thalassemia / Q000188:drug therapy; D014786:Vision Disorders / Q000139:chemically induced; D015009:Yersinia Infections / Q000139:chemically induced
D004247:DNA; D003676:Deferoxamine